Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human alpha 1-microglobulin in various hepatic disorders.

Y Itoh, H Enomoto, K Takagi

    Digestion
    |January 1, 1983
    PubMed
    Summary

    Serum alpha 1-microglobulin (alpha 1-m) decreases significantly in severe liver diseases like cirrhosis and fulminant hepatitis, indicating the liver

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Adverse Drug Event Profile Associated with Anti-dementia Drugs: Analysis of a Spontaneous Reporting Database.

    Die Pharmazie·2023
    Same author

    Low incidence of hepatitis B virus reactivation and subsequent hepatitis in patients with chronic hepatitis C receiving direct-acting antiviral therapy.

    Journal of viral hepatitis·2017
    Same author

    Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein for patients with chronic hepatitis B and C: a comparative study.

    Journal of viral hepatitis·2016
    Same author

    A rare variant in CYP27A1 and its association with atopic dermatitis with high serum total IgE.

    Allergy·2016
    Same author

    Is greater than 145{degrees} of deep knee flexion under weight-bearing conditions safe after total knee arthroplasty?: a fluoroscopic analysis of Japanese-style deep knee flexion.

    The bone & joint journal·2013
    Same author

    Anti-interferon-α neutralizing antibody is associated with nonresponse to pegylated interferon-α plus ribavirin in chronic hepatitis C.

    Journal of viral hepatitis·2012

    Area of Science:

    • Biochemistry
    • Hepatology
    • Clinical Chemistry

    Background:

    • Alpha 1-microglobulin (alpha 1-m) is a protein found in serum and urine.
    • The liver is a primary site for protein synthesis.
    • The role of alpha 1-m in liver disease is not fully understood.

    Purpose of the Study:

    • To investigate human alpha 1-microglobulin (alpha 1-m) levels in patients with various liver diseases.
    • To assess the correlation between alpha 1-m levels and liver function markers.
    • To determine the potential of alpha 1-m as a biomarker for liver damage severity.

    Main Methods:

    • Quantification of alpha 1-m in serum and urine samples from patients with different liver conditions.
    • Comparison of alpha 1-m levels with those of healthy individuals.
    • Statistical analysis to determine significant differences and correlations.

    Main Results:

    • Alpha 1-m levels were within the normal range in acute and chronic hepatitis.
    • Significant decreases in serum alpha 1-m were observed in compensated and decompensated liver cirrhosis.
    • The most pronounced decrease in alpha 1-m was noted in fulminant hepatitis.
    • Serum alpha 1-m levels correlated positively with serum albumin, plasma fibrinogen, and cholinesterase activity.
    • Urinary alpha 1-m levels were significantly lower in decompensated liver cirrhosis patients compared to controls.

    Conclusions:

    • The liver plays a crucial role in the synthesis of alpha 1-microglobulin.
    • Decreased serum and urinary alpha 1-m levels are indicative of severe liver damage.
    • Alpha 1-m quantitation may serve as a valuable tool for evaluating the severity of liver disease.

    Related Experiment Videos